Compare LNTH & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | PSN |
|---|---|---|
| Founded | 1956 | 1944 |
| Country | United States | United States |
| Employees | N/A | 14200 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 4.8B |
| IPO Year | 2014 | 2019 |
| Metric | LNTH | PSN |
|---|---|---|
| Price | $100.45 | $45.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $87.00 | $79.18 |
| AVG Volume (30 Days) | 903.8K | ★ 957.2K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.77 |
| EPS | ★ 2.91 | 0.49 |
| Revenue | $343,374,000.00 | ★ $6,364,245,000.00 |
| Revenue This Year | N/A | $5.87 |
| Revenue Next Year | $14.19 | $7.61 |
| P/E Ratio | ★ $34.57 | $91.72 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $49.67 | $36.26 |
| 52 Week High | $111.86 | $89.50 |
| Indicator | LNTH | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 43.47 | 42.43 |
| Support Level | $99.92 | $45.00 |
| Resistance Level | $101.43 | $49.61 |
| Average True Range (ATR) | 0.46 | 1.51 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 9.80 | 22.05 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.